These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21170322)

  • 1. Transmitted drug resistance in persons with acute/early HIV-1 in San Francisco, 2002-2009.
    Jain V; Liegler T; Vittinghoff E; Hartogensis W; Bacchetti P; Poole L; Loeb L; Pilcher CD; Grant RM; Deeks SG; Hecht FM
    PLoS One; 2010 Dec; 5(12):e15510. PubMed ID: 21170322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Transmitted HIV Drug Resistance Among Recently Infected Persons in San Diego, CA 1996-2013.
    Panichsillapakit T; Smith DM; Wertheim JO; Richman DD; Little SJ; Mehta SR
    J Acquir Immune Defic Syndr; 2016 Feb; 71(2):228-36. PubMed ID: 26413846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study.
    Drescher SM; von Wyl V; Yang WL; Böni J; Yerly S; Shah C; Aubert V; Klimkait T; Taffé P; Furrer H; Battegay M; Ambrosioni J; Cavassini M; Bernasconi E; Vernazza PL; Ledergerber B; Günthard HF; Kouyos RD;
    Clin Infect Dis; 2014 Jan; 58(2):285-94. PubMed ID: 24145874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmitted drug resistance and molecular transmission network among treatment-naive HIV-1 patients in Wenzhou, China, 2020-2023.
    Zhang T; Dou H; Ye H; Tang H; Wang W; Hu W; Lv B; Zhou M; Dai H; Wang W; Sun B
    Virol J; 2024 Oct; 21(1):257. PubMed ID: 39420358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naïve persons in rural western Kenya.
    Onywera H; Maman D; Inzaule S; Auma E; Were K; Fredrick H; Owiti P; Opollo V; Etard JF; Mukui I; Kim AA; Zeh C
    PLoS One; 2017; 12(2):e0171124. PubMed ID: 28178281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First line treatment response in patients with transmitted HIV drug resistance and well defined time point of HIV infection: updated results from the German HIV-1 seroconverter study.
    Zu Knyphausen F; Scheufele R; Kücherer C; Jansen K; Somogyi S; Dupke S; Jessen H; Schürmann D; Hamouda O; Meixenberger K; Bartmeyer B
    PLoS One; 2014; 9(5):e95956. PubMed ID: 24788613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012.
    Yang WL; Kouyos R; Scherrer AU; Böni J; Shah C; Yerly S; Klimkait T; Aubert V; Furrer H; Battegay M; Cavassini M; Bernasconi E; Vernazza P; Held L; Ledergerber B; Günthard HF;
    J Infect Dis; 2015 Jul; 212(1):28-38. PubMed ID: 25576600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in HIV-1-transmitted drug resistance among ART-naïve youths at the China-Myanmar border during 2009 ~ 2017.
    Ding Y; Chen M; Wang J; Yang Y; Feng Y; Wang L; Duan S; Lin Q; Xing H; Ma Y; Han M; Ma L
    BMC Infect Dis; 2021 Jan; 21(1):93. PubMed ID: 33478415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmitted antiretroviral drug resistance in New York State, 2006-2008: results from a new surveillance system.
    Readhead AC; Gordon DE; Wang Z; Anderson BJ; Brousseau KS; Kouznetsova MA; Forgione LA; Smith LC; Torian LV
    PLoS One; 2012; 7(8):e40533. PubMed ID: 22879878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV drug resistance and HIV transmission risk factors among newly diagnosed individuals in Southwest China.
    Pang X; Tang K; He Q; Huang J; Fang N; Zhou X; Zhu Q; Wu X; Shen Z; Liang S
    BMC Infect Dis; 2021 Feb; 21(1):160. PubMed ID: 33557775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and patterns of HIV transmitted drug resistance in Guatemala.
    Avila-Ríos S; Mejía-Villatoro CR; García-Morales C; Soto-Nava M; Escobar I; Mendizabal R; Girón A; García L; Reyes-Terán G
    Rev Panam Salud Publica; 2011 Dec; 30(6):641-8. PubMed ID: 22358416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study Cohort.
    Machnowska P; Meixenberger K; Schmidt D; Jessen H; Hillenbrand H; Gunsenheimer-Bartmeyer B; Hamouda O; Kücherer C; Bannert N;
    PLoS One; 2019; 14(1):e0209605. PubMed ID: 30650082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmitted Drug Resistance and HIV Diversity Among Adolescents Newly Diagnosed With HIV in Spain.
    Epalza C; Valadés-Alcaraz A; González-Alba JM; Beltrán-Pavez C; Gutiérrez-López M; Rubio-Garrido M; Fortuny C; Frick MA; Muñoz Medina L; Moreno S; Sanz J; Rojo P; Navarro ML; Holguín Á;
    Pediatr Infect Dis J; 2024 Jan; 43(1):40-48. PubMed ID: 37922511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016.
    Rossetti B; Di Giambenedetto S; Torti C; Postorino MC; Punzi G; Saladini F; Gennari W; Borghi V; Monno L; Pignataro AR; Polilli E; Colafigli M; Poggi A; Tini S; Zazzi M; De Luca A;
    HIV Med; 2018 Oct; 19(9):619-628. PubMed ID: 29932313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of HIV-1 transmitted drug resistance and viral suppression among recently diagnosed adults in São Paulo, Brazil.
    Coelho LPO; Matsuda EM; Nogueira RS; de Moraes MJ; Jamal LF; Madruga JVR; Tancredi MV; de Leão ACQ; de Faria Romero Soldi G; de Macedo Brígido LF;
    Arch Virol; 2019 Mar; 164(3):699-706. PubMed ID: 30569276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological surveillance of HIV-1 transmitted drug resistance among newly diagnosed individuals in Shijiazhuang, northern China, 2014-2015.
    Wang X; Liu X; Li F; Zhou H; Li J; Wang Y; Liu L; Liu S; Feng Y; Wang N
    PLoS One; 2018; 13(6):e0198005. PubMed ID: 29870534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low prevalence of transmitted drug resistance of HIV-1 during 2008-2012 antiretroviral therapy scaling up in Southern Vietnam.
    Tanuma J; Quang VM; Hachiya A; Joya A; Watanabe K; Gatanaga H; Van Vinh Chau N; Chinh NT; Oka S
    J Acquir Immune Defic Syndr; 2014 Aug; 66(4):358-64. PubMed ID: 24815852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of transmitted HIV-1 drug resistance among treatment-naive individuals in China, 2000-2016.
    Yuan H; Liu Z; Wu X; Wu M; Fang Q; Zhang X; Shi T; Tully DC; Zhang T
    Arch Virol; 2021 Sep; 166(9):2451-2460. PubMed ID: 34195923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of misclassification of antiretroviral treatment status on the prevalence of transmitted HIV-1 drug resistance.
    Castro H; Pillay D; Sabin C; Dunn DT;
    BMC Med Res Methodol; 2012 Mar; 12():30. PubMed ID: 22416878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Emergence of HIV-1 Transmitted Drug Resistance Mutations Among Antiretroviral Therapy-naive Individuals in Buleleng, Bali, Indonesia.
    Megasari NLA; Oktafiani D; Fitriana E; Khairunisa SQ; Kotaki T; Ueda S; Nasronudin N; Soetjipto S; Kameoka M
    Acta Med Indones; 2019 Jul; 51(3):197-204. PubMed ID: 31699942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.